BioWorld

Oct. 8, 2002

McClellan Breezes Through First Meeting Before Senate Committee

WASHINGTON - Nominee Mark McClellan easily jumped the first hurdle in becoming the next commissioner of the FDA from a largely absent Senate committee. (Bioworld Today) Read More

New Erbitux Trials Starting; ImClone Has Second Chance'

Phylogeny Test Opens Novel Path To Forensic Crime Detection, First In U.S.; Forecast As Future Model

Cell Therapeutics Starts NSCLC Phase III, Eyes One More In 2002

Quorex Enhances Platform By Acquiring Bioinformatics Firm

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Jan 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 13, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Science in 2025: the best of the rest

BioWorld Science

A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.

LINC01116 has prognostic value in lung cancer, study shows

BioWorld MedTech

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...